The LymphGen classification subgrouped the 3 FL/tFL as “EZB”, and 2 GCB DLBCL patients as “ST2”, while Pat1 (non-GCB DLBCL) carried a NOTCH1 mutation and was subgrouped as “N1”. Here, NOTCH1 is linked to diffuse large B-cell lymphoma.